Moderna had been awarded over $750 million to develop a vaccine against bird flu, which has been circulating in farm animals and sickening people.

Bird flu, for the moment, appears to be under control. But experts have a warning for federal and state health officials.

Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...

The Trump administration has terminated a multi-million-dollar contract with Massachusetts-based Moderna to support its late-stage development of a bird flu vaccine for humans. The company ...

Moderna MRNA recently announced that the U.S. government has terminated the previously-awarded contract for the late-stage development of an mRNA-based bird flu vaccine, as well as the right to ...

Despite efforts to spare employees by scaling back R&D and reducing operating costs by roughly $1.5 billion over the next two ...

Earlier this month, Moderna said it no longer expects to get approval for a combined COVID-19 and flu shot this year. The company said it may continue developing the bird flu vaccine on its own.

Moderna will not be developing a vaccine to protect against bird flu — at least on the federal government’s dime. The U.S. Department of Health and Human Services canceled a contract with the ...

Moderna said Wednesday that an early-phase trial of its mRNA-based vaccine against H5 bird flu in about 300 healthy adults showed “a rapid, potent and durable immune response.” ...

Moderna said Wednesday that an early-phase trial of its mRNA-based vaccine against H5 bird flu in about 300 healthy adults showed “a rapid, potent and durable immune response.” ...

Moderna said Wednesday that an early-phase trial of its mRNA-based vaccine against H5 bird flu in about 300 healthy adults showed “a rapid, potent and durable immune response.” ...